Metabolomic, lipidomic and proteomic characterisation of lipopolysaccharide-induced inflammation mouse model

Neuroinflammation is an important feature in the pathogenesis and progression of central nervous system (CNS) diseases including Alzheimer’s disease (AD). One of the widely used animal models of peripherally induced neuroinflammation and neurodegeneration is a lipopolysaccharide (LPS)-induced inflam...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Puris, Elena (VerfasserIn) , Kouřil, Štěpán (VerfasserIn) , Najdekr, Lukáš (VerfasserIn) , Auriola, Seppo (VerfasserIn) , Loppi, Sanna (VerfasserIn) , Korhonen, Paula (VerfasserIn) , Gómez-Budia, Mireia (VerfasserIn) , Fricker, Gert (VerfasserIn) , Kanninen, Katja M. (VerfasserIn) , Malm, Tarja (VerfasserIn) , Friedecký, David (VerfasserIn) , Gynther, Mikko (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 29 June 2022
In: Neuroscience
Year: 2022, Jahrgang: 496, Pages: 165-178
ISSN:1873-7544
DOI:10.1016/j.neuroscience.2022.05.030
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.neuroscience.2022.05.030
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0306452222002706
Volltext
Verfasserangaben:Elena Puris, Štěpán Kouřil, Lukáš Najdekr, Seppo Auriola, Sanna Loppi, Paula Korhonen, Mireia Gómez-Budia, Gert Fricker, Katja M. Kanninen, Tarja Malm, David Friedecký and Mikko Gynther

MARC

LEADER 00000caa a2200000 c 4500
001 1831412446
003 DE-627
005 20230707002421.0
007 cr uuu---uuuuu
008 230118s2022 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.neuroscience.2022.05.030  |2 doi 
035 |a (DE-627)1831412446 
035 |a (DE-599)KXP1831412446 
035 |a (OCoLC)1389536372 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Puris, Elena  |e VerfasserIn  |0 (DE-588)1211100596  |0 (DE-627)1698938217  |4 aut 
245 1 0 |a Metabolomic, lipidomic and proteomic characterisation of lipopolysaccharide-induced inflammation mouse model  |c Elena Puris, Štěpán Kouřil, Lukáš Najdekr, Seppo Auriola, Sanna Loppi, Paula Korhonen, Mireia Gómez-Budia, Gert Fricker, Katja M. Kanninen, Tarja Malm, David Friedecký and Mikko Gynther 
264 1 |c 29 June 2022 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar 28 Mai 2022, Artikelversion 29 Juni 2022 
500 |a Gesehen am 18.01.2023 
520 |a Neuroinflammation is an important feature in the pathogenesis and progression of central nervous system (CNS) diseases including Alzheimer’s disease (AD). One of the widely used animal models of peripherally induced neuroinflammation and neurodegeneration is a lipopolysaccharide (LPS)-induced inflammation mouse model. An acute LPS administration has been widely used for investigation of inflammation-associated disease and testing inflammation-targeting drug candidates. In the present metabolomic, lipidomic and proteomic study, we investigated short-term effects of systemic inflammation induced by LPS administration on the mouse plasma and brain cortical and hippocampal metabolome, lipidome as well as expression of the brain cortical proteins which were shown to be involved in inflammation-associated CNS diseases. From a global perspective, the hippocampus was more vulnerable to the effects of LPS-induced systemic inflammation than the cortex. In addition, the study revealed several brain region-specific changes in metabolic pathways and lipids, such as statistically significant increase in several cortical and hippocampal phosphatidylcholines/phosphatidylethanolamines, and significantly decreased levels of brain cortical betaine after LPS treatment in mice. Moreover, LPS treatment in mice caused significantly increased protein expression of GluN1 receptor in the brain cortex. The revealed perturbations in the LPS-induced inflammation mouse model may give insight into the mechanisms underlying inflammation-associated CNS diseases. In addition, the finding of the study provide important information about the appropriate use of the model during target validation and drug candidate testing. 
650 4 |a Alzheimer’s disease 
650 4 |a lipidomics 
650 4 |a lipopolysaccharide 
650 4 |a metabolomics 
650 4 |a proteomics 
700 1 |a Kouřil, Štěpán  |e VerfasserIn  |4 aut 
700 1 |a Najdekr, Lukáš  |e VerfasserIn  |4 aut 
700 1 |a Auriola, Seppo  |e VerfasserIn  |4 aut 
700 1 |a Loppi, Sanna  |e VerfasserIn  |4 aut 
700 1 |a Korhonen, Paula  |e VerfasserIn  |4 aut 
700 1 |a Gómez-Budia, Mireia  |e VerfasserIn  |4 aut 
700 1 |a Fricker, Gert  |d 1956-  |e VerfasserIn  |0 (DE-588)1042227675  |0 (DE-627)768469465  |0 (DE-576)393783464  |4 aut 
700 1 |a Kanninen, Katja M.  |e VerfasserIn  |4 aut 
700 1 |a Malm, Tarja  |e VerfasserIn  |4 aut 
700 1 |a Friedecký, David  |e VerfasserIn  |4 aut 
700 1 |a Gynther, Mikko  |e VerfasserIn  |0 (DE-588)126240617X  |0 (DE-627)1810072557  |4 aut 
773 0 8 |i Enthalten in  |t Neuroscience  |d Amsterdam [u.a.] : Elsevier Science, 1976  |g 496(2022), Seite 165-178  |h Online-Ressource  |w (DE-627)306588625  |w (DE-600)1498423-4  |w (DE-576)081953089  |x 1873-7544  |7 nnas  |a Metabolomic, lipidomic and proteomic characterisation of lipopolysaccharide-induced inflammation mouse model 
773 1 8 |g volume:496  |g year:2022  |g pages:165-178  |g extent:14  |a Metabolomic, lipidomic and proteomic characterisation of lipopolysaccharide-induced inflammation mouse model 
856 4 0 |u https://doi.org/10.1016/j.neuroscience.2022.05.030  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0306452222002706  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230118 
993 |a Article 
994 |a 2022 
998 |g 126240617X  |a Gynther, Mikko  |m 126240617X:Gynther, Mikko  |d 160000  |d 160100  |e 160000PG126240617X  |e 160100PG126240617X  |k 0/160000/  |k 1/160000/160100/  |p 12  |y j 
998 |g 1042227675  |a Fricker, Gert  |m 1042227675:Fricker, Gert  |d 160000  |d 160100  |e 160000PF1042227675  |e 160100PF1042227675  |k 0/160000/  |k 1/160000/160100/  |p 8 
998 |g 1211100596  |a Puris, Elena  |m 1211100596:Puris, Elena  |d 160000  |d 160100  |e 160000PP1211100596  |e 160100PP1211100596  |k 0/160000/  |k 1/160000/160100/  |p 1  |x j 
999 |a KXP-PPN1831412446  |e 4249515699 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"display":"Puris, Elena","given":"Elena","roleDisplay":"VerfasserIn","role":"aut","family":"Puris"},{"display":"Kouřil, Štěpán","role":"aut","roleDisplay":"VerfasserIn","given":"Štěpán","family":"Kouřil"},{"family":"Najdekr","display":"Najdekr, Lukáš","role":"aut","roleDisplay":"VerfasserIn","given":"Lukáš"},{"family":"Auriola","given":"Seppo","roleDisplay":"VerfasserIn","role":"aut","display":"Auriola, Seppo"},{"display":"Loppi, Sanna","role":"aut","roleDisplay":"VerfasserIn","given":"Sanna","family":"Loppi"},{"family":"Korhonen","roleDisplay":"VerfasserIn","role":"aut","given":"Paula","display":"Korhonen, Paula"},{"family":"Gómez-Budia","given":"Mireia","roleDisplay":"VerfasserIn","role":"aut","display":"Gómez-Budia, Mireia"},{"family":"Fricker","roleDisplay":"VerfasserIn","role":"aut","given":"Gert","display":"Fricker, Gert"},{"family":"Kanninen","given":"Katja M.","role":"aut","roleDisplay":"VerfasserIn","display":"Kanninen, Katja M."},{"given":"Tarja","roleDisplay":"VerfasserIn","role":"aut","display":"Malm, Tarja","family":"Malm"},{"given":"David","role":"aut","roleDisplay":"VerfasserIn","display":"Friedecký, David","family":"Friedecký"},{"display":"Gynther, Mikko","roleDisplay":"VerfasserIn","role":"aut","given":"Mikko","family":"Gynther"}],"relHost":[{"id":{"issn":["1873-7544"],"eki":["306588625"],"zdb":["1498423-4"]},"corporate":[{"display":"International Brain Research Organization","role":"isb","roleDisplay":"Herausgebendes Organ"}],"note":["Gesehen am 20.02.20"],"recId":"306588625","part":{"extent":"14","year":"2022","pages":"165-178","text":"496(2022), Seite 165-178","volume":"496"},"pubHistory":["1.1976 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"Neuroscience","title":"Neuroscience","subtitle":"an international journal under the editorial direction of IBRO"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"1976-","publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1976"}],"language":["eng"],"disp":"Metabolomic, lipidomic and proteomic characterisation of lipopolysaccharide-induced inflammation mouse modelNeuroscience"}],"name":{"displayForm":["Elena Puris, Štěpán Kouřil, Lukáš Najdekr, Seppo Auriola, Sanna Loppi, Paula Korhonen, Mireia Gómez-Budia, Gert Fricker, Katja M. Kanninen, Tarja Malm, David Friedecký and Mikko Gynther"]},"id":{"eki":["1831412446"],"doi":["10.1016/j.neuroscience.2022.05.030"]},"physDesc":[{"extent":"14 S."}],"origin":[{"dateIssuedDisp":"29 June 2022","dateIssuedKey":"2022"}],"title":[{"title":"Metabolomic, lipidomic and proteomic characterisation of lipopolysaccharide-induced inflammation mouse model","title_sort":"Metabolomic, lipidomic and proteomic characterisation of lipopolysaccharide-induced inflammation mouse model"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1831412446","note":["Online verfügbar 28 Mai 2022, Artikelversion 29 Juni 2022","Gesehen am 18.01.2023"]} 
SRT |a PURISELENAMETABOLOMI2920